Gene therapy is expected to open a new strategy for the treatment of refractory vascular diseases, so the development of appropriate gene vectors for vascular lesions is needed. To realize this requirement with a non-viral approach, cyclo(RGDfK) peptide (cRGD) was introduced to block copolymer, poly(ethylene glycol)-block-polycation carrying ethylenediamine units (PEG-PAsp(DET)). cRGD recognizes a v b 3 and a v b 5 integrins, which are abundantly expressed in vascular lesions. cRGDconjugated PEG-PAsp(DET) (cRGD-PEG-PAsp(DET)) formed polyplex micelles through complexation with plasmid DNA (pDNA) and the cRGD-PEG-PAsp(DET) micelles achieved significantly more efficient gene expression and cellular uptake as compared with PEG-PAsp(DET) micelles in endothelial cells and vascular smooth muscle cells. Intracellular tracking of pDNA showed that cRGD-PEG-PAsp(DET) micelles were internalized via caveolae-mediated endocytosis, which is associated with a pathway avoiding lysosomal degradation and that, PEG-PAsp(DET) micelles were transported to acidic endosomes and lysosomes via clathrin-mediated endocytosis. Further, in vivo evaluation in rat carotid artery with a neointimal lesion revealed that cRGD-PEG-PAsp(DET) micelles realized sustained gene expression, whereas PEG-PAsp(DET) micelles facilitated rapid, but transient gene expression. These findings suggest that introduction of cRGD to polyplex micelles might create novel and useful functions for gene transfer and contribute to the establishment of efficient gene therapy for vascular diseases.
INTRODUCTION
Therapeutic application of gene delivery techniques is expected to open a new strategy for the treatment of refractory vascular disease and a variety of methods have been proposed for delivering therapeutic genes to vascular wall cells. 1, 2 In these methods, viral vectors have been mostly utilized as the gene carrier, as gene transfer efficiency with viral vectors is generally superior to that of other non-viral methods. However, there are some limitations in the clinical application of viral vectors, the most critical of which could be the problem of safety due to antigenicity and oncogenicity. 3, 4 These issues of viral vectors have impelled the development of non-viral vectors with safe and reasonably efficient gene transfer. 5, 6 Polyplex and lipoplex systems, in which plasmid DNA (pDNA) forms a polyion complex with cationic polymers and cationic lipids, respectively, have been widely studied as conventional non-viral vectors. [7] [8] [9] [10] It is known that polyplex and lipoplex potentially achieve desirable efficiency of gene transfer in vitro. However, positive charges on these vectors potentially induce cytotoxicity and nonspecific aggregation with plasma proteins, indicating that in vivo administration of these vectors might be considerably restricted. 11, 12 Polyplex micelles were developed to resolve these restrictions of non-viral vectors. They are constructed from newly synthesized block copolymer characterized by tandem alignment of a hydrophilic polyethylene glycol (PEG) segment and a polycationic segment. [13] [14] [15] A proper mixture of block copolymer and pDNA potently forms stable polyplex micelles that possess a unique core-shell structure of a hydrophilic shell layer surrounding a polyplex core. 16, 17 Because of the hydrophilic property of the PEG shell, the polyplex micelle minimizes nonspecific interactions with various bio-components, realizing high biocompatibility and stability in vivo. [18] [19] [20] In previous studies, we also designed PEG-block-polycation carrying ethylenediamine units (PEG-PAsp(DET)) in the side chain and reported that polyplex micelles with PEG-PAsp(DET) accomplished appreciable gene transfer efficiency with low cytotoxicity. 20, 21 After internalization of PEG-PAsp(DET) micelles into the intracellular compartment by endocytosis, the ethylenediamine units are expected to promote translocation of the polyplex micelles toward the cytoplasm due to endosomal membrane destabilization, resulting in improvement of gene transfer efficiency. 22, 23 Furthermore, to increase cellular uptake of polyplex micelles, we recently attempted to introduce appropriate ligands into their surface. [24] [25] [26] The installed ligands potently enhanced uptake into the targeted cells by inducing receptor-mediated endocytosis, whereas polyplex micelles without ligands were taken up only through adsorptive or fluid-phase endocytosis.
In the present study, cyclo(RGDfK) peptide (cRGD) was introduced to the PEG terminal of PEG-PAsp(DET) in order to function as a specific ligand on the surface of the polyplex micelle ( Figure 1 ). cRGD peptide selectively recognizes a v b 3 and a v b 5 integrins, 27 and previous studies showed that a v b 3 and a v b 5 are abundantly expressed on endothelial cells and smooth muscle cells in vascular lesions. [28] [29] [30] PEG-PAsp(DET) micelles installed with cRGD (cRGD-PEG-PAsp (DET) micelles) were applied to endothelial cells and vascular smooth muscle cells in vitro and also to rat carotid artery with neointimal hyperplasia, and the efficacy of gene transfer was evaluated as compared with that of ligand-free PEG-PAsp(DET) micelles.
RESULTS
Expression of a v b 3 and a v b 5 integrins on HUVEC and VSMC To evaluate the expression of a v b 3 and a v b 5 integrins on vascular wall cells, flow cytometric analysis of human umbilical vein endothelial cells (HUVEC; Cambrex Corporation, East Rutherford, NJ, USA) and human vascular smooth muscle cells (VSMC) was carried out using fluorescein isothiocyanate-labeled antibodies against a v b 3 and a v b 5 . Flow cytometric analysis revealed considerable expression of a v b 3 and a v b 5 on HUVEC and VSMC, respectively, as compared with control (Figures 2a and b ). In contrast, little expression of a v b 3 and a v b 5 was detected on 293 T cells used as negative control (Figure 2c ).
Expression of avb3 was also confirmed by immunoprecipitation using a complex-specific antibody against avb3. Immunoprecipitation followed by immunoblotting with anti-b3 antibody clearly demonstrated the presence of avb3 in HUVEC and VSMC, whereas it was not detected in 293 T cells ( Figure 2d ).
In vitro gene transfer to HUVEC and VSMC
The expression plasmid vector containing the luciferase gene was complexed with cRGD-PEG-PAsp(DET) at various N/P ratios and applied to HUVEC or VSMC in vitro. Here, N/P ratio refers to the unit molar ratio of amino groups in the polymer to phosphate groups in the pDNA. Gene expression was assessed by measuring luciferase activity 24 h later and polyplex micelles with PEG-PAsp(DET) were utilized in the same manner as control. Regarding gene transfer to HUVEC, luciferase activity after treatment with cRGD-PEG-Pasp (DET) micelles was significantly higher than that with PEG-PAsp (DET) micelles at N/P ratios of 5 and 10 ( Figure 3a ). At N/P ratios of 2, 20 and 30, no remarkable difference in luciferase activity was detected between cRGD-PEG-PAsp(DET) micelles and PEG-PAsp (DET) micelles, though the activity was appreciably higher at N/P ratios of 20 and 30. Regarding gene transfer to VSMC, cRGD-PEG-PAsp(DET) micelles showed significantly higher luciferase activity at N/P ratios of 4 and 5, as compared with PEG-PAsp(DET) micelles, whereas there was no difference in activity between the two types of micelles at N/P ratios of 2, 10 and 20 ( Figure 3b ). . Fluorescein isothiocyanate-labeled antibodies against avb3 integrin (blue), avb5 integrin (red) or mouse IgG (black) were added to each cell suspension, followed by incubation on ice in the dark. Lowest panel (d) shows immnoprecipitation findings of HUVEC, VSMC and 293 T cells. Each cell lysate was immunoprecipitated with a complex-specific antibody against a v b 3 and then immune complexes were immunoblotted with anti-b 3 antibody.
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Inhibition of gene transfer by adding free cRGD peptides
To confirm receptor-mediated transfer due to cRGD peptide, HUVEC or VSMC were pretreated with various concentrations of free cRGD peptides and then applied with cRGD-PEG-PAsp(DET) micelles or PEG-PAsp(DET) micelles containing luciferase gene (N/P¼5). In both cells, luciferase activity at 24 h showed that gene expression after treatment with cRGD-PEG-PAsp(DET) micelles was clearly inhibited with increasing concentrations of free cRGD peptides (Figure 3c ), whereas no significant change was detected after treatment with PEG-PAsp(DET) micelles ( Figure 3d ).
Cellular uptake of polyplex micelles
To assess uptake of cRGD-PEG-PAsp(DET) micelles into vascular cells in vitro, Cy5-labeled pDNA (Cy5-pDNA) was complexed with cRGD-PEG-PAsp(DET) at N/P ratio of 5, and administered to HUVEC or VSMC in vitro. Intensity of Cy5 incorporated into these cells was analyzed by flow cytometry at 0.5, 1, 3 and 6 h after administration. PEG-PAsp(DET) micelles containing Cy5-pDNA were used as control.
In both HUVEC and VSMC, the intracellular intensity of Cy5 after transfer with cRGD-PEG-PAsp(DET) micelles was significantly higher than that with PEG-PAsp(DET) micelles at all time points except 6 h in VSMC (Figures 4a and b ).
Intracellular distribution of polyplex micelles
Other sets of cultured HUVEC and VSMC were also treated with cRGD-PEG-PAsp(DET) micelles or PEG-PAsp(DET) micelles containing Cy5-pDNA and the intracellular distribution of Cy5-pDNA (red) was evaluated at 6 and 24 h by confocal laser scanning microscopy (CLSM). Simultaneously, HUVEC and VSMC were stained with LysoTracker Green (green) to identify acidic endosomes and lysozomes, or cholera toxin subunit B (CT-B) Alexa Fluor 488 (green) for lipid rafts and caveosomes and colocalization with incorporated Cy5-pDNA was quantified. In HUVEC, intracellular Cy5-pDNA after transfer with PEG-PAsp(DET) micelles considerably colocalized with LysoTracker Green as compared with that with cRGD-PEG-PAsp(DET) micelles at 6 and 24 h after treatment ( Figure 5b ). On the contrary, Cy5-pDNA after transfer with cRGD-PEG-PAsp(DET) micelles markedly colocalized with CT-B as compared with that of PEG-PAsp(DET) micelles ( Figure 5a ). These findings were statistically confirmed by quantitative analyses using colocalization ratio (Figures 5c and d) . The same experiments using VSMC showed similar results. Cy5-pDNA transferred with cRGD-PEG-PAsp(DET) micelles tended to colocalize with intracellular CT-B and that with PEG-PAsp(DET) micelles tended to associate with LysoTracker Green at both 6 and 24 h after application of micelles, which were confirmed by statistical analyses (Figures 5e-h) .
Gene transfer to neointimal lesion induced in rat carotid artery
Rat carotid artery was injured with a balloon catheter, which induced neointimal hyperplasia by 21 days after injury. Expression pDNA fused with luciferase gene was complexed with cRGD-PEG-PAsp(DET) at N/P ratio of 5, and polyplex micelles were administered into the carotid artery with neointima. The carotid arteries were sampled at 1, 2, 3 and 4 days after treatment, and luciferase activity of the carotids was measured to evaluate gene expression in the arteries. PEG-PAsp(DET) micelles complexed with luciferase pDNA (N/P ratio¼5) were applied in the same manner as control. In carotid arteries subjected to cRGD-PEG-PAsp(DET) micelles, maximum luciferase activity was observed at 2 days after application of micelles, and activity on day 3 and 4 was similar to that on day 1 (Figure 6a ). On the contrary, in the arteries treated with PEG-PAsp(DET) micelles, luciferase activity showed a maximum value on day 1, though only low level activity was detected on day 3 and 4. Statistical analyses showed that on day 1, activity of carotid samples treated with PEG-PAsp(DET) micelles was significantly higher than that with cRGD-PEG-PAsp(DET) micelles. However, on day 3 and 4, arterial samples after treatment with cRGD-PEG-PAsp(DET) micelles showed significantly higher luciferase activity as compared with those after application of PEG-PAsp(DET) micelles. There was no difference in values on day 2 between the two groups. pDNA was also complexed with cRGD-PEG-PAsp(DET) or PEG-PAsp(DET) at N/P ratio of 20. The micelles were applied into carotid arteries with neointima in the same manner. In carotid arteries subjected to cRGD-PEG-PAsp(DET) micelles and also those with PEG-PAsp(DET), luciferase activity was markedly lower on day 2 and also day 3, which was significantly lower than that after application of micelles with N/P ratio of 5 (Figures 6b and c).
In vivo uptake of polyplex micelles
To evaluate in vivo uptake of polyplex micelles in the rat carotid artery with neointima, Cy3-labeled pDNA was complexed with cRGD-PEG-PAsp(DET) or PEG-PAsp(DET) at N/P ratio of 5, and the micelles were administered into the arteries (Figure 7) . At 1 day after application of micelles, the carotid arteries were excised and cross sections were analyzed with a fluorescence microscope. In carotid arteries subjected to cRGD-PEG-PAsp(DET) micelles, considerable diffuse fluorescence of Cy3 was observed in all of the neointimal layer, whereas scarce fluorescence was detected in arteries treated with PEG-PAsp(DET) micelles (Figures 7a and b ). Cy3 intensity in the neointima was quantified as fluorescence intensity index and the index after treatment with cRGD-PEG-PAsp(DET) micelles was significantly higher than that with PEG-PAsp(DET) micelles (Figure 7c ).
DISCUSSION
In the present study, cRGD peptide was introduced to the surface of polyplex micelles with PEG-PAsp(DET) as a specific ligand for a v b 3 and a v b 5 , and its gene transfer efficacy to vascular wall cells and lesion-induced artery was analyzed in comparison with that of ligandfree PEG-PAsp(DET) micelles. PEG-PAsp(DET) micelles complexed with pDNA tightly pack the DNA into a dense shell layer of hydrophilic PEG, assuring high stability and biocompatibility in vivo. 16, 17 Further, after cellular uptake by endocytosis, the ethylenediamine units of polycation are potently protonated in the endosome and considered to promote desirable translocation toward the cytoplasm due to endosomal membrane destabilization. 22, 23 Our previous study indeed showed that administration of PEG-PAsp(DET) micelles into rabbit carotid artery accomplished appreciable gene transfer to the artery, without occlusion by thrombus formation. 20 In contrast, the same study revealed that polyplex made from polyethyleneimine markedly caused thrombus occlusion after intra-arterial application, indicating that positively charged polyplex potentially underwent aggregation with plasma proteins and blood cells. As thrombus formation possibly interferes with the process of gene transfer and further impairs vascular functions, it appears necessary for gene vectors for the treatment of vascular diseases to possess non-thrombogenic properties, like PEG-PAsp(DET) micelles.
It is known that a v b 3 and a v b 5 integrins are expressed on various vascular cells such as endothelial cells, smooth muscle cells and macrophages, and that they have an important role in atherogenesis and formation of other vascular lesions, which was a rational basis for selection of cRGD peptide as a ligand of the gene vector for vascular lesions. 28, [31] [32] [33] [34] [35] In the present study, HUVEC and VSMC were used for in vitro study. We were initially concerned about the possibility that integrins expressed on HUVEC and VSMC markedly differed from those on endothelial cells and smooth muscle cells in vascular lesions in vivo, as neither of these cells was harvested from the diseased artery. However, flow cytometry revealed obvious expression of a v b 3 and a v b 5 on HUVEC and VSMC, indicating that these cells were appropriate for in vitro evaluation of the micelles.
In vitro study using the luciferase gene showed that gene expression after transfer with cRGD-PEG-PAsp(DET) micelles was significantly higher than that with PEG-PAsp(DET) micelles in both HUVEC and VSMC at low N/P ratios. This finding clearly demonstrated that introduction of cRGD potently improved the gene expression efficiency of the micelles at low N/P ratios. Previously, we have also reported similar findings experimentally using Hela cells, which abundantly express a v b 3 and a v b 5 , although care must be taken to extrapolate from properties of cell lines. The previous study showed marked improvement of gene expression in Hela cells after delivery with cRGD-fused polyplex micelles, whereas no improvement was detected in 293 T cells expressing little a v b 3 and a v b 5 . 36 One possible mechanism explaining the improvement might be that the association of cRGD ligands with a v b 3 and a v b 5 integrins efficiently enhanced cellular uptake of polyplex micelles through receptor-mediated endocytosis. Indeed, in HUVEC and VSMC, pretreatment with free cRGD peptides clearly inhibited the improvement of gene transfer with cRGD-PEG-PAsp(DET) micelles (N/P¼5), suggesting a contribution of receptor-mediated uptake due to the cRGD ligand. 37 Further, cellular uptake of Cy5-pDNA after treatment with cRGD-PEG-PAsp(DET) micelles (N/P¼5) was significantly higher than that with PEG-PAsp(DET) micelles (N/P¼5) at 0.5, 1 and 3 h after treatment. Another possible mechanism for the improved gene expression with cRGD-PEG-PAsp(DET) micelles might be that cRGD ligands modulated intracellular trafficking after uptake of the polyplex micelles. In CLSM analyses of HUVEC and VSMC, pDNA transferred with cRGD-PEG-PAsp(DET) micelles tended to colocalize with lipid rafts and caveosomes, whereas pDNA after transfer with PEG-PAsp(DET) micelles tended to associate with acidic endosomes and lysosomes. Grosse et al. 38 evaluated the cellular uptake of particles that were not installed with any ligands and showed that the process of cellular uptake depended upon particle size; particles with 4200 nm diameter were internalized by macropinocytosis, particles with 100-200 nm diameter by clathrin-mediated endocytosis and particles o100 nm diameter by caveolae-mediated endocytosis. The average diameter of cRGD-PEG-PAsp(DET) and PEG-PAsp(DET) micelles was around 100 nm, with a moderate distribution. As PEG-PAsp(-DET) micelles were particles without ligands, a main process in cellular uptake of PEG-PAsp(DET) micelles was then suspected to be clathrin-mediated endocytosis and the principle components of the endocytic pathway are endosomes and lysozomes, supporting the CLSM findings on PEG-PAsp(DET) micelles. Meanwhile, previous studies showed that expression of a v b 3 integrins promoted cellular uptake via caveolae-mediated endocytosis and that, a v b 5 expression facilitated clathrin-mediated endocytosis. [39] [40] [41] As the binding affinity of cRGD with a v b 3 is 10 times stronger than that with a v b 5 , it might be reasonable that caveolae-mediated endocytosis was a dominant process in the cellular uptake of cRGD-PEG-PAsp(DET) micelles. 42 In contrast to clathrin-mediated endocytosis, the internalization pathway via caveolae-mediated endocytosis is known to bypass degradative organelles and not to be associated with a decrease in pH. Therefore, it is possible that cRGD-PEG-PAsp(DET) micelles enabled avoidance of enzymatic degradation after internalization via caveolae-mediated endocytosis, resulting in enhanced gene expression. Meanwhile, at a high N/P ratio, no remarkable difference in gene expression on HUVEC and VSMC was detected between treatment with cRGD-PEG-PAsp(DET) micelles and that with PEG-PAsp(DET) micelles. When polyplex micelle solution is prepared at a higher N/P ratio, the obtained solution generally contains more free copolymers. 43 In gene transfer with cRGD-PEG-PAsp(DET) micelles, free cRGD-PEG-PAsp(DET) copolymer in solution consequently competes with cRGD-PEG-PAsp(DET) micelles for association with a v b 3 and a v b 5 on cells. The competitive effect due to free copolymer might be a reason for weak ligand function of cRGD-PEG-PAsp(DET) micelles at a high N/P ratio.
The principal aim of the present study was to evaluate gene transfer efficacy to vascular lesions using cRGD-PEG-PAsp(DET) micelles and PEG-PAsp(DET) micelles. Vascular lesions as the target of gene therapy are generally related to atherosclerosis or its associated diseases and such lesions develop from the intimal layer of the arterial wall. The major cell components of intimal lesions are intimal SMC and monocytes/macrophages, and previous studies showed that the biological properties of these cells were markedly different from those of medial SMC and other cells in normal artery. 44, 45 Thus, to develop gene transfer methods targeting vascular lesions, in vivo experiments must be carried out on artery with intimal lesions, not normal artery.
In the present study, we induced neointimal hyperplasia in the rat carotid artery by balloon injury and then administered polyplex micelles into the same artery, which might be an appropriate model to acquire highly reliable data on vascular gene transfer.
In vivo study using the luciferase gene showed that overall gene expression with polyplex micelles at N/P ratio of 5 was markedly higher than that at N/P ratio of 20, and the time-course of gene expression revealed a clear contrast between delivery with cRGD-PEG-PAsp(DET) micelles (N/P¼5) and that with PEG-PAsp(DET) micelles (N/P¼5). Namely, delivery with cRGD-PEG-PAsp(DET) micelles facilitated sustained gene expression, whereas that with PEG-PAsp (DET) micelles promoted rapid, but transient expression of the transferred gene. The contrast in gene expression between these micelles could be explained by the difference in intracellular trafficking after endocytosis. As the cRGD peptide possesses high affinity for a v b 3 , cRGD-PEG-PAsp(DET) micelles might be predominantly internalized through caveolae-mediated endocytosis, whereby the micelles undergo neither enzymatic degradation nor pH decrease during intracellular trafficking. 46 The avoidance of enzymatic degradation potentially prolonged the half-life of pDNA in the cells and then realized sustained expression of the transferred gene. The absence of a decrease in pH indicated that endosomal membrane destabilization was hardly caused by PAsp(DET) polycation of cRGD-PEG-PAsp (DET) micelles, which possibly delayed translocation of the gene toward the cytoplasm. The present study indeed showed that gene expression at 1 day after treatment with cRGD-PEG-PAsp(DET) micelles was considerably lower than that with PEG-PAsp (DET) micelles, although in vivo uptake of Cy3-pDNA at 1 day after treatment with cRGD-PEG-PAsp(DET) micelles was significantly superior to that with PEG-PAsp(DET) micelles. In contrast, PEG-PAsp(DET) micelles might be mostly internalized via clathrinmediated endocytosis and then transported to the endosomes. A low pH in the endosomes potentially protonated some PEG-PAsp(DET) micelles and accelerated translocation of the gene toward the cytoplasm by endosomal membrane destabilization, which might promote rapid expression of the transferred gene. However, as other PEG-PAsp(DET) micelles were inevitably transported to the lysozomes and digested by enzymatic hydrolysis, gene expression might tend to be transient. We consider that such a difference in the gene expression pattern suggests the possibility of combined application of cRGD-PEG-PAsp(DET) and PEG-PAsp(DET) micelles. If both micelles were simultaneously administered to the targeted artery, it might be feasible to achieve rapid and sustained gene expression in the arterial wall.
In conclusion, polyplex micelles with cRGD-PEG-PAsp(DET) achieved significantly more efficient gene expression and cellular uptake as compared with ligand-free PEG-PAsp(DET) micelles in both HUVEC and VSMC, which expressed a v b 3 and a v b 5 integrins. Tracer study of pDNA showed that cRGD-PEG-PAsp(DET) micelles were internalized into HUVEC and VSMC via caveolae-mediated endocytosis, and that PEG-PAsp(DET) micelles were internalized via clathrin-mediated endocytosis. Further, in vivo evaluation in rat carotid artery with neointimal hyperplasia revealed that cRGD-PEG-PAsp(DET) micelles realized sustained gene expression, whereas PEG-PAsp(DET) micelles facilitated rapid, but transient gene expression. These findings demonstrated that cRGD-PEG-PAsp(DET) and PEG-PAsp(DET) micelles possessed different characteristics of gene expression in vivo and efficiently functioned as non-viral gene vectors for vascular lesions.
MATERIALS AND METHODS
Synthesis of cRGD-PEG-PAsp(DET) and PEG-PAsp(DET)
Acetal-PEG-PAsp(DET) was prepared as previously reported. 21 Briefly, b-benzyl-L-aspartate N-carboxyanhydride was polymerized in N,N-dimethylformamide/CH 2 Cl 2 (1:10) at 35 1C by initiation from the primary amino group of acetal-PEG-NH 2 (Mw of PEG: 12 000 g mol À1 ). Acetal-PEG-b-poly(b-benzyl L-aspartate) was recovered by precipitation in an excess amount of n-hexane/ AcoEt (6:4) and the filtrate was dried in vacuo. The degree of polymerization of poly(b-benzyl L-aspartate) was calculated as 68 from the 1 H nuclear magnetic resonance spectrum (data not shown). The side-chain aminolysis reaction of poly(b-benzyl L-aspartate) was then performed by mixing with a 50-fold excess of diethylenetriamine (DET) in N-methylpyrrolidone at 0 1C to obtain acetal-PEG-PAsp(DET). Introduction of cRGD peptide (Peptide Institute, Osaka, Japan) into block copolymer was carried out as previously reported. 36 Briefly, acetal-PEG-PAsp(DET) was added to cRGD peptide in 0.2 M AcOH buffer (pH 4.0) and stirred at room temperature for 5 days. The reacted polymer was purified by dialysis with 0.01 N HCl and distilled water and lyophilized to obtain cRGD-PEG-PAsp(DET). The introduction rate of the cRGD peptide ligands was determined to be 45% from the 1 H nuclear magnetic resonance spectrum (data not shown).
Detection of a v b 3 and a v b 5 integrins on HUVEC and VSMC HUVEC (Cambrex Corporation), cultured in endothelial basal medium-2 medium containing growth supplement (Lonza, Walkersville, MD, USA) and human VSMC (Applied Cell Biology Research Institute, Kirkland, WA, USA), cultured in Cell System-Corporation medium (Applied Cell Biology Research Institute), were detached by trypsin treatment and 5Â10 5 cells were resuspended in 100 ml endothelial basal medium-2 medium for HUVEC and Cell System-Corporation medium for VSMC. Fluorescein isothiocyanate-labeled antibody against a v b 3 integrin, a v b 5 integrin or mouse IgG (2 mg; Cosmo Bio Co., Ltd, Tokyo, Japan) was added to each cell suspension, followed by incubation on ice for 1 h in the dark. The cells were washed three times with cold medium and, after being resuspended in PBS, were analyzed by flow cytometry (BD LSR II instrument, BD Biosciences, Franklin Lakes, NJ, USA). As negative control, 5Â10 5 293 T cells were treated with antibodies and analyzed in the same manner. This experiment was performed twice.
Immunoprecipitation of a v b 3 integrin
As integrins are hetetodimers consisting of aand b-subunits, expression of a v b 3 was evaluated by immunoprecipitation, using a complex-specific antibody for a v b 3 (LM609, Millipore, Temecula, CA, USA). HUVEC, VSMC and 293 T cells were lysed in ImmunoPrecipitation lysis buffer (100 mmol l À1 Tris, pH 7.0, 10% glycerol, 1% Triton X-100 and protease inhibitors). Cell lysate (100 mg total protein) was diluted in 0.5 ml ImmunoPrecipitation lysis buffer and treated with anti-a v b 3 antibody (5 ml) at 4 1C for 16 h after pre-cleaning with Protein G-Sepharose (GE Healthcare, Uppsala, Sweden). Immune complexes were recovered with Protein G-Sepharose (GE Healthcare) and washed twice with ImmunoPrecipitation lysis buffer. Samples were separated on 8% sodium dodecyl sulpgate-polyacrylamide gel electrophoresis and blotted onto nitrocellulose membrane. The blot was immunostained with anti-b 3 antibody (sc-14009, Santa Cruz Biotechnology, Santa Cruz, CA, USA) and visualized with an ECL Plus system (GE Healthcare).
Plasmids
Plasmid pCAccluc+ was constructed by inserting the recombinant luciferase gene (luc+) into the pCAGGS expression vector. Plasmids were grown in competent DH5a E. coli and purified with a HiSpeed Plasmid MaxKit (QIAGEN, Germantown, MD, USA). In order to analyze the localization of the transferred gene, pDNA was labeled with Cy5 or Cy3 (Label IT kits, Pierce Co., Inc., Rockford, IL, USA).
Preparation of polyplex micelles
cRGD-PEG-PAsp(DET), PEG-PAsp(DET) and pDNA were separately dissolved in 10 mM HEPES buffer (pH 7.4). The polymer solution was added to a twofold excess volume of pDNA solution to form polyplex micelles at various N/P ratios, the residual molecular ratio of amino groups in the block copolymer to phosphate groups in pDNA.
In vitro gene transfer to HUVEC and VSMC
HUVEC and VSMC were seeded on a 24-well culture plate (20 000 cells per well) and cultured overnight in 500 ml endothelial basal medium-2 or Cell System-Corporation medium, respectively. pCAccluc+ was complexed with cRGD-PEG-PAsp(DET) or PEG-PAsp(DET), and N/P ratios of the polyplex micelles were adjusted to 2, 5, 10, 20 and 30 for gene transfer to HUVEC and 2, 4, 5, 10 and 20 for gene transfer to VSMC. After replacement with fresh culture medium, 30 ml micelle solution (33.3 mg pDNA ml À1 ) was applied to each well (1 mg pDNA per well) (n¼3) and incubated at 37 1C. At 24 h after application of micelle solution, the cells were lysed in 100 ml cell culture lysis reagent (Promega, Tokyo, Japan) and luciferase activity was evaluated using a Luciferase assay kit (Promega) and a Lumat LB9507 luminometer (Berthold Technologies, Bad Wildbad, Germany). The results were expressed as relative light units per mg of total protein.
Inhibition assay with free cRGD peptides pCAccluc+ was complexed with cRGD-PEG-PAsp(DET) or PEG-PAsp(DET) at N/P ratio of 5. The medium of HUVEC or VSMC cultured in a 24-well plate was replaced with fresh medium containing various concentrations of cRGD peptide, followed by 3 h incubation. Then, 30 ml micelle solution (33.3mg pDNA ml À1 ) was applied to each well (1 mg pDNA per well) (n¼4). After 24 h incubation, luciferase activity of the cells was measured in the same manner.
Cellular uptake of polyplex micelles
HUVEC or VSMC were seeded on six-well culture plates (100 000 cells per well) and incubated overnight in 2 ml of each medium. Cy5-pDNA was complexed with cRGD-PEG-PAsp(DET) or PEG-PAsp(DET) at N/P ratio of 5, and 90 ml of each micelle solution (33.3 mg pDNA ml À1 ) was applied to each well (3 mg pDNA per well) after replacement with fresh culture medium and incubated at 37 1C. At 0.5, 1, 3 and 6 h after application of micelle solution (n¼4), the medium was removed and the cells were washed three times with PBS. After detachment with trypsin, the cells were re-suspended in PBS and analyzed by flow cytometry.
Intracellular distribution of incorporated pDNA
HUVEC and VSMC were seeded on 35-mm glass base dishes (100 000 cells per dish; Iwaki, Tokyo, Japan) and incubated overnight in 2 ml of each medium. After medium change, 90 ml polyplex micelle (containing Cy5-pDNA) solution (N/P¼5, 33.3 mg pDNA ml À1 ) was applied to a glass base dish and incubated for 6 or 24 h (n¼3). The intracellular distribution of the polyplex micelles was observed with a CLSM after staining acidic endosomes and lysosomes with LysoTracker Green (Molecular Probes, Eugene, OR, USA) or lipid rafts and caveosomes with CT-B Alexa Fluor 488 (Molecular Probes). CLSM observation was performed using an LSM 510 (Carl Zeiss, Oberlochen, Germany) with a C-Apochromat Â63 objective (Carl Zeiss) at a suitable excitation wavelength.
To evaluate the final destination of polyplex micelles, the rate of colocalization of Cy5-pDNA with LysoTracker Green or CT-B Alexa Fluor 488 was quantified. LysoTracker Green (Molecular Probes) was used as a marker of late endosomes and lysosomes and CT-B Alexa Fluor 488 (Molecular Probes) was used as a marker of lipid rafts and caveosomes. Colocalization was quantified as follows:
where Pix colocalization represents the number of Cy5 pixels colocalizing with LysoTracker Green or CT-B Alexa Fluor 488 and Pix total represents the number of all pixels in the cell.
Animal model and evaluation of gene expression efficiency
All animal experiments were approved by the Institutional Animal Care and Use Committee and conducted in conformity with institutional guidelines. SD rats (weight, 300-400 g; Kurea, Tokyo Japan) fed with a normal diet were anesthetized by intraperitoneal injection of ketamine (75 mg kg À1 ) and xylazine (10 mg kg À1 ). A 2-Fr Fogarty balloon catheter (Baxter Healthcare, Deerfield, IL, USA) was introduced through the first branch of the left external carotid artery and passed into the left common carotid artery. The balloon was inflated at physiological pressure and passed through the common carotid artery three times with constant rotation. 20 At 21 days after balloon injury, polyplex micelles were administered into the common carotid artery, in which neointimal hyperplasia had been induced. pCAccluc+ was complexed with cRGD-PEG-PAsp(DET) or PEG-PAsp(DET) at N/P ratio of 5. Then, proximal sites of the common carotid artery and internal carotid artery were clamped with a vessel clip and a PE-10 tube (Clay Adams, West Chester, PA, USA) was introduced into the common carotid artery through the external carotid artery. After flushing with Ringer's solution, 200 ml of each micelle solution (20 mg pDNA ml À1 ) was gently infused into the common carotid artery through the tube (4 mg pDNA). The distal common carotid artery was then clamped and the common carotid artery was left for 20 min. The vessel clips of the carotid artery were then removed and the arterial circulation was restored. Animals were killed at 1, 2, 3 and 4 days after administration of micelles (n¼6-8) and the left common carotid artery was excised. After removal of surrounding connective tissue, each sample was homogenized and lysed in 300 ml cell culture lysis reagent and luciferase activity of each lysate was measured. Gene transfer efficiency was evaluated as the ratio of luciferase activity to the protein content. The results were expressed as relative light units per mg protein.
Additionally, pCAccluc+ was also complexed with cRGD-PEG-PAsp(DET) or PEG-PAsp(DET) at N/P ratio of 20 and other groups of rats were treated with micelle solutions (N/P¼20) in the same manner. These animals were killed at 2 and 3 days after administration (n¼4-5) and luciferase activity was measured.
In vivo uptake of polyplex micelles
To evaluate in vivo uptake of polyplex micelles in the carotid artery with neointima, Cy3-pDNA was complexed with cRGD-PEG-PAsp(DET) or PEG-PAsp(DET) at N/P ratio of 5. The rats were subjected to balloon injury and 21 days later, 200 ml of each micelle solution (20 mg pDNA ml À1 ) was administered to the neointima-induced carotid artery in the same manner (n¼3). At 1 day after administration, the carotid arteries were excised and frozen sections (4 mm thick) were cut out. Cross sections of the arteries were analyzed using a fluorescent digital microscope (BZ-8000, Keyence, Osaka, Japan) with a suitable filter set. Briefly, the ring-shaped arterial cross section was radially divided into five parts and a fluorescent photomicrograph of each part was acquired as digital data. The fluorescence intensity in the neointima was quantified as pixel number (Pix neointima ), using image analysis software (WinROOF, Mitani Corporation, Fukui, Japan). As the elastic laminae of the medial layer possessed weak autonomous fluorescence, the pixel number of the elastic laminae was also quantified (Pix eleastic ) and the fluorescence intensity of the neointima was standardized as follows:
Fluorescence intensity index ¼ Pix neointima =Pix eleastic The mean fluorescence intensity indexes of five parts were used as the value of each cross section.
Statistical analysis
All values are shown as mean ± s.e.m. Statistical significance was determined by two-sided Mann-Whitney U-test. Differences with Po0.05 were considered significant.
